BNP PARIBAS ASSET MANAGEMENT Holding S.A.

Position in NVCR — NovoCure Ltd

CIK 1520354 Paris, I0

Position in NVCR

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$5,555,096

+$727,139 QoQ

Shares Held

509,642

+36.5% QoQ

Ownership

0.440%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $1,569,205,986 across 40 Medical Devices names. NVCR ranks #17 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	6,966,229	$437,130,867
2	EW	Edwards Lifesciences Corp	2,104,677	$168,542,532
3	DXCM	Dexcom Inc	2,466,523	$154,897,644
4	MDT	Medtronic plc	1,510,419	$130,877,804
5	SYK	Stryker Corp	351,521	$115,506,284
6	ABT	Abbott Laboratories	967,639	$99,347,493
7	GMED	Globus Medical Inc	1,145,540	$98,699,725
8	IRTC	iRhythm Holdings, Inc.	762,062	$89,938,556

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,555,096	509,642	+36.5%	Shares	Defined	2026-05-14
2025-12-31	$4,827,957	373,392	+32284.4%	Shares	Defined	2026-02-13
2025-09-30	$14,896	1,153	+9.8%	Shares	Defined	2025-11-07
2025-06-30	$18,690	1,050	-90.5%	Shares	Defined	2025-08-06
2023-06-30	$460,235	11,090	-89.7%	Shares	Defined	2023-08-08
2023-03-31	$6,458,795	107,396	-2.9%	Shares	Defined	2023-05-08
2022-12-31	$8,115,590	110,642	-3.8%	Shares	Defined	2023-02-10
2022-09-30	$8,739,827	115,028	-1.3%	Shares	Defined	2022-11-10
2022-06-30	$8,101,198	116,564	+4220.4%	Shares	Defined	2022-08-04
2022-03-31	$223,529	2,698	—	Shares	Defined	2022-05-12
No filing history on record for this holder in this stock.